Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$1.25 - $1.92 $62,500 - $96,000
50,000 Added 54.23%
142,200 $179,000
Q1 2023

May 15, 2023

BUY
$1.29 - $2.46 $118,938 - $226,812
92,200 New
92,200 $184,000
Q2 2022

Aug 15, 2022

SELL
$0.93 - $1.9 $32,550 - $66,500
-35,000 Reduced 60.74%
22,625 $22,000
Q1 2022

May 16, 2022

SELL
$1.85 - $2.75 $18,500 - $27,500
-10,000 Reduced 14.79%
57,625 $111,000
Q4 2021

Feb 14, 2022

SELL
$2.19 - $4.07 $32,850 - $61,050
-15,000 Reduced 18.15%
67,625 $148,000
Q3 2021

Nov 15, 2021

BUY
$3.67 - $5.8 $183,500 - $290,000
50,000 Added 153.26%
82,625 $307,000
Q1 2021

May 17, 2021

SELL
$5.11 - $9.24 $93,518 - $169,101
-18,301 Reduced 35.94%
32,625 $215,000
Q4 2020

Feb 16, 2021

BUY
$4.36 - $6.51 $109,000 - $162,750
25,000 Added 96.43%
50,926 $287,000
Q1 2020

May 15, 2020

BUY
$3.5 - $13.77 $27,741 - $109,141
7,926 Added 44.03%
25,926 $149,000
Q4 2019

Feb 14, 2020

SELL
$6.21 - $14.02 $24,840 - $56,080
-4,000 Reduced 18.18%
18,000 $246,000
Q1 2019

May 15, 2019

BUY
$3.35 - $8.27 $35,175 - $86,835
10,500 Added 91.3%
22,000 $155,000
Q4 2018

Feb 14, 2019

SELL
$3.23 - $8.7 $237,728 - $640,320
-73,600 Reduced 86.49%
11,500 $40,000
Q3 2018

Nov 13, 2018

BUY
$8.4 - $12.6 $714,840 - $1.07 Million
85,100 New
85,100 $119,000

Others Institutions Holding ARAV

About Aravive, Inc.


  • Ticker ARAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,518,300
  • Description
  • Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...
More about ARAV
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.